CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
HIV-specific CD8 T cells and broadly neutralizing antibodies (bNAbs) both contribute to the control of viremia, but in most cases, neither can completely suppress viral replication. To date, therapeutic vaccines have not been successful in eliciting HIV-specific CD8 T cell or bNAb responses that are...
Main Authors: | Rebecca T. Veenhuis, Caroline C. Garliss, Justin R. Bailey, Joel N. Blankson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.708355/full |
Similar Items
-
A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants
by: Hok Yee Chan, et al.
Published: (2020-04-01) -
The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
by: Victoria E. Walker-Sperling, et al.
Published: (2016-06-01) -
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
by: Salgado Maria, et al.
Published: (2011-12-01) -
Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
by: Lok Bahadur Shrestha, et al.
Published: (2021-09-01) -
Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?
by: Sarah E. Beck, et al.
Published: (2019-10-01)